Diphenoxylate HCl 2.5 mg / atropine sulfate 0.025 mg Oral Tablet
RxNorm 1190572
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1190572 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: diphenoxylate HCl 2.5 mg / atropine sulfate 0.025 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Atropine sulfate 0.025 mg / diphenoxylate hydrochloride 2.5 mg Oral Tablet
(Atom ID: 12331912)
PTPrescribable
Designated preferred name (PT):
Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet
(Atom ID: 10294518)
PSNPrescribable
Prescribable Name (PSN):
Diphenoxylate HCl 2.5 mg / atropine sulfate 0.025 mg Oral Tablet
(Atom ID: 6362203)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 10309565)
Patient Education
Diphenoxylate
Diphenoxylate is used along with other treatments such as fluid and electrolyte replacement for the treatment of diarrhea. Diphenoxylate should not be given to children younger than 2 years of age. Diphenoxylate is in a class of medications called antidiarrheal agents. It works by decreasing activity of the bowel.
[Learn More]
* Please review the disclaimer below.